BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15062285)

  • 1. Prognostic factors in melanoma outcome and survival.
    Le TT; Pitman KT
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):33-41. PubMed ID: 15062285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Follow-up of malignant melanoma].
    Truchetet F; Chartier C; Heid E
    Ann Dermatol Venereol; 1989; 116(5):437-40. PubMed ID: 2675740
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prognostic factors and improving treatment of cutaneous melanoma].
    Vihinen P; Kähäri VM; Pyrhönen S
    Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of sentinel lymph node biopsy in the management of thin melanoma.
    Wong SL
    Am J Surg; 2005 Aug; 190(2):196-9. PubMed ID: 16023430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Skin melanoma].
    Lääkäriseuran S;
    Duodecim; 2005; 121(24):2725-39. PubMed ID: 16869061
    [No Abstract]   [Full Text] [Related]  

  • 7. [Malignant melanoma. Pathological anatomy].
    Wechsler J; Belaich S
    Rev Prat; 1993 Sep; 43(13):1743-6. PubMed ID: 8303202
    [No Abstract]   [Full Text] [Related]  

  • 8. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.
    Thomas JM
    J Clin Oncol; 2005 Dec; 23(36):9443-4. PubMed ID: 16361650
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic index in malignant melanoma. A better method to determine metastasis risk].
    Schmoeckel C; Nejad KK; Braun-Falco O
    Pathologe; 1980 Feb; 1(2):71-8. PubMed ID: 7208436
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemotherapy for melanoma: rational therapeutics in the search for weapons of melanoma destruction.
    Margolin KA
    Cancer; 2004 Aug; 101(3):435-8. PubMed ID: 15274056
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic models for melanoma.
    Elder DE
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():68-75. PubMed ID: 20482678
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of extent of ulceration in primary cutaneous melanoma.
    Grande Sarpa H; Reinke K; Shaikh L; Leong SP; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2006 Nov; 30(11):1396-400. PubMed ID: 17063079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rational surgical approach to the treatment of distant melanoma metastases.
    Martinez SR; Young SE
    Cancer Treat Rev; 2008 Nov; 34(7):614-20. PubMed ID: 18556133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging.
    Gimotty PA; Guerry D; Ming ME; Elenitsas R; Xu X; Czerniecki B; Spitz F; Schuchter L; Elder D
    J Clin Oncol; 2004 Sep; 22(18):3668-76. PubMed ID: 15302909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.
    Moehrle M; Schippert W; Rassner G; Garbe C; Breuninger H
    Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of melanoma micrometastases in the sentinel lymph node.
    Giblin AV; Hayes AJ; Thomas JM
    Eur J Surg Oncol; 2005 Dec; 31(10):1103-4. PubMed ID: 16084052
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.
    Ben-Porat L; Panageas KS; Hanlon C; Patel A; Halpern A; Houghton AN; Coit D
    Cancer; 2006 Jan; 106(1):163-71. PubMed ID: 16331596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma.
    Califano J; Nance M
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy: facts to clear the alleged clouds.
    Morton DL; Elashoff R
    Arch Dermatol; 2008 May; 144(5):685-6; author reply 687. PubMed ID: 18490604
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of microsatellites as a prognostic factor in primary malignant melanoma.
    Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
    Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.